Wealth Enhancement Advisory Services, LLC Arrowhead Pharmaceuticals, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $37 Billion
- Q1 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Arrowhead Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 8,536 shares of ARWR stock, worth $213,997. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,536
Previous 8,432
1.23%
Holding current value
$213,997
Previous $258,000
5.43%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ARWR
# of Institutions
296Shares Held
88.5MCall Options Held
905KPut Options Held
387K-
Black Rock Inc. New York, NY15.3MShares$385 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA12.4MShares$311 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY8.56MShares$214 Million2.95% of portfolio
-
State Street Corp Boston, MA6.56MShares$164 Million0.01% of portfolio
-
Slate Path Capital LP New York, NY4.14MShares$104 Million2.38% of portfolio
About ARROWHEAD PHARMACEUTICALS, INC.
- Ticker ARWR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 105,849,000
- Market Cap $2.65B
- Description
- Arrowhead Pharmaceuticals, Inc. develops medicines for the treatment of intractable diseases in the United States. The company's products in pipeline includes ARO-AAT, a RNA interference (RNAi) therapeutic candidate that is in Phase II clinical trial for the treatment of liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, w...